Neuroendocrine Mechanisms and Therapeutics in an Animal Model of PTSD

PTSD 动物模型的神经内分泌机制和治疗方法

• 批准号: 8394609
• 负责人: David Mark Diamond
• 金额: --
• 依托单位: JAMES A. HALEY VA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-10-01 至 2014-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8394609
• 关键词: AMPA Receptors; Acetylation; Acute; Address; Adrenergic Antagonists; Adverse effects; Affect; Amygdaloid structure; Animal Model; Anticonvulsants; Antidepressive Agents; Anxiety; Anxiety Disorders; Area; Attenuated; BDNF gene; Behavior; Behavioral; Biological; Biological Assay; Brain; CRF receptor type 1; Calcium; Calmodulin; Cardiovascular system; Chromatin; Cognitive; Cognitive deficits; Complex; Corticosterone; Corticotropin-Releasing Hormone; Cyclic AMP-Responsive DNA-Binding Protein; DNA Methylation; Development; Disease model; Effectiveness; Emotional; Endocrine system; Epigenetic Process; Epinephrine; Etiology; Event; Exhibits; Feedback; Felis catus; Fright; Functional disorder; Funding; Glucocorticoid Receptor; Glucocorticoids; Glutamates; Goals; Health; Heart Diseases; Hippocampus (Brain); Histone H3; Hormonal; Hospitalization; Human; Hydrocortisone; Hypothalamic structure; Immune system; Incidence; Individual; Laboratories; Learning; Link; Measures; Medical Research; Memory; Mental Depression; Mental Health; Mental disorders; Metabolic; Methylation; Mineralocorticoid Receptor; Mineralocorticoids; Modeling; Molecular; Mood Disorders; N-Methyl-D-Aspartate Receptors; Neurobiology; Neurosecretory Systems; Non-Insulin-Dependent Diabetes Mellitus; Paper; Pharmacological Treatment; Pharmacotherapy; Phenotype; Phosphorylation; Phosphotransferases; Physiological; Post-Traumatic Stress Disorders; Prefrontal Cortex; Process; Psyche structure; Psychosocial Stress; Rattus; Receptor Activation; Reducing Agents; Regimen; Regulation; Research; Retrieval; Signal Transduction; Signaling Molecule; Stress; Symptoms; System; Testing; Therapeutic; Therapeutic Studies; Tissues; Trauma; Veterans; Work; Yohimbine; base; brain behavior; cardiovascular disorder risk; channel blockers; clinical efficacy; combat; conditioned fear; corticosterone receptor; effective therapy; emotional trauma; experience; high risk; hypothalamic-pituitary-adrenal axis; improved; insight; lamotrigine; mRNA Expression; meetings; memory process; memory retrieval; physical conditioning; population health; programs; public health relevance; receptor; research study; response; social; stressor; therapeutic development; tianeptine

DESCRIPTION (provided by applicant): We have developed an animal model of post-traumatic stress disorder (PTSD) based on the combination of inescapable cat exposure and social instability. This psychosocial stress manipulation produces PTSD-like sequelae in rats, including heightened anxiety, exaggerated startle, impaired memory, greater cardiovascular and hormonal reactivity to an acute stressor and an exaggerated response to the 12-adrenergic receptor antagonist, yohimbine. The proposed research will apply our PTSD model to study therapeutics which may block the development of PTSD-like sequelae, to understand the neurobiological basis of traumatic memory formation and retrieval and to examine the neuroendocrine mechanisms which underlie PTSD-like sequelae. The following three questions address the specific aims of this proposal. 1) Will pharmacological treatments which reduce glutamate and CRF activity block PTSD-like sequelae in rats? Research has demonstrated the involvement of glutamate and corticotropin-releasing factor (CRF) in traumatic memory formation and in the pathophysiology of PTSD. Pharmacotherapy that will target these two neuromodulatory systems has the potential to ameliorate the complex cluster of symptoms present in people with PTSD. We hypothesize that treatment with 1) Tianeptine, an antidepressant which stabilizes NMDA receptor currents; 2) Lamotrigine, a Na+ channel blocker which reduces glutamate levels; or 3) a CRH-1 receptor antagonist, will block the development of PTSD-like sequelae in psychosocially stressed rats. 2) What are the mechanisms underlying the formation and persistence of traumatic memories? The hallmark feature of PTSD is the establishment and persistence of a pathologically intense memory of a traumatic event. We will examine molecular mechanisms involved in the formation and remote memory retrieval of the fear conditioning component of our PTSD model. Specifically, we will study the influence of predator-induced fear conditioning to activate molecular signalling molecules, including calcium/calmodulin- dependent kinase II (CaMKII) and cAMP-response element binding protein (CREB), in response to the traumatic experience and then, weeks later, to a reminder of that experience. Second, we will study epigenetic plasticity which may underlie the formation and long-term persistence of traumatic memories. Specifically, we will assess the effects of psychosocial stress on BDNF gene methylation in the hippocampus, amygdala and prefrontal cortex. 3) Does psychosocial stress in rats produce PTSD-like abnormalities in neuroendocrine activity? PTSD involves disturbances of neuroendocrine systems, including reduced basal glucocorticoid levels and increased glucocorticoid negative feedback sensitivity, as well as changes in CRF levels and glucocorticoid receptors. We will evaluate whether our psychosocial stress regimen produces a PTSD-like phenotype in corticosterone responses, glucocorticoid receptors and CRF levels in the hypothalmus, hippocampus and amygdala. Overall, the goal of these three complementary approaches is to use our animal model of PTSD to provide insight into the neuroendocrine and mechanistic features of PTSD and to develop more effective treatments of stress-induced anxiety and mood disorders. CLINICAL RELEVANCE: Veterans exposed to traumatic stress during combat have a high incidence of anxiety disorders, such as PTSD. We have yet to achieve a satisfactory understanding of the etiology of stress-induced sequelae and how to effectively treat stress-related mental disorders. This research will enhance our understanding of the neurobiology of traumatic memory processing and aid in the development of therapeutic treatments for PTSD.

描述（由申请人提供）： 我们基于不可避免的猫暴露和社会不稳定的结合，开发了一种创伤后应激障碍（PTSD）的动物模型。这种心理社会应激操作在大鼠中产生PTSD样后遗症，包括焦虑加剧、过度惊吓、记忆受损、对急性应激源的心血管和激素反应性增强以及对12-肾上腺素能受体拮抗剂育亨宾的反应过度。拟议的研究将应用我们的PTSD模型来研究可能阻止PTSD样后遗症发展的治疗方法，以了解创伤记忆形成和恢复的神经生物学基础，并检查PTSD样后遗症背后的神经内分泌机制。以下三个问题涉及这项建议的具体目标。1)降低谷氨酸和CRF活性的药物治疗是否会阻断大鼠PTSD样后遗症？研究表明谷氨酸和促肾上腺皮质激素释放因子（CRF）参与创伤记忆的形成和PTSD的病理生理学。针对这两种神经调节系统的药物治疗有可能改善PTSD患者的复杂症状。我们假设，1）噻奈普汀（一种稳定NMDA受体电流的抗抑郁药）; 2）拉莫三嗪（一种降低谷氨酸水平的Na+通道阻滞剂）;或3）CRH-1受体拮抗剂治疗将阻断心理社会应激大鼠中PTSD样后遗症的发展。2)创伤记忆形成和持续的机制是什么？创伤后应激障碍的标志性特征是对创伤事件的病理性强烈记忆的建立和持续。我们将研究创伤后应激障碍模型中恐惧条件反射成分的形成和远程记忆提取所涉及的分子机制。具体来说，我们将研究捕食者诱导的恐惧条件反射对激活分子信号分子的影响，包括钙/钙调蛋白依赖性激酶II（CaMKII）和cAMP反应元件结合蛋白（CREB），以响应创伤经历，然后，几周后，提醒这种经历。其次，我们将研究表观遗传可塑性，这可能是创伤记忆形成和长期持续的基础。具体来说，我们将评估心理社会压力对海马、杏仁核和前额皮质BDNF基因甲基化的影响。3)心理社会应激是否会导致大鼠神经内分泌活动的PTSD样异常？创伤后应激障碍涉及神经内分泌系统的紊乱，包括基础糖皮质激素水平降低和糖皮质激素负反馈敏感性增加，以及CRF水平和糖皮质激素受体的变化。我们将评估我们的心理社会应激方案是否在下丘脑、海马和杏仁核的皮质酮反应、糖皮质激素受体和CRF水平中产生PTSD样表型。 总的来说，这三种互补方法的目标是利用我们的PTSD动物模型来深入了解PTSD的神经内分泌和机制特征，并开发更有效的治疗应激诱导的焦虑和情绪障碍的方法。临床相关性：在战斗中暴露于创伤应激的退伍军人有很高的焦虑症发病率，如创伤后应激障碍。我们还没有达到一个令人满意的理解的病因应激引起的后遗症，以及如何有效地治疗应激相关的精神障碍。这项研究将增强我们对创伤记忆处理的神经生物学的理解，并有助于开发创伤后应激障碍的治疗方法。